Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Roflumilast in the Treatment of Psoriasis - a Randomised Controlled Trial

NCT04549870 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT04549870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04549870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Roflumilast in the Treatment of Psoriasis - a Randomised Controlled Trial
Lead sponsor
Bispebjerg Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2021
Completion date
December 12, 2022
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis